Improvement of Transition From Hospital to Home for Older Patients in Germany
TIGER
Transsectoral Intervention Program for Improvement of Geriatric Care in Regensburg
1 other identifier
interventional
252
1 country
2
Brief Summary
The aim of the transsectoral care project TIGER is the reduction of readmission rates of geriatric patients. This aim shall be achieved by improving the hitherto inadequate care process for geriatric patients in the transition from hospital to home. The program offers substantial support of patients and their informal caregivers in the transition process from hospital to home via so called pathfinders, specialized nurses in geriatrics.The pathfinders effectively intertwine stationary and ambulatory care teams caring for a patient, thereby augmenting and complementing effective hospital release management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2018
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2018
CompletedStudy Start
First participant enrolled
April 25, 2018
CompletedFirst Posted
Study publicly available on registry
May 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2021
CompletedMarch 3, 2021
March 1, 2021
2.2 years
April 17, 2018
March 2, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Readmission Rate
The number of readmissions of a patient into a hospital within up to 15 months (study period for the patient.plus 3 months prior to enrollment).
up to 12 months
Secondary Outcomes (14)
Functionality and mobility - 1
up to 12 months
Functionality and mobility - 2
up to 12 months
Functionality and mobility - 3
up to 12 months
Functionality and mobility - 4
up to 12 months
Functionality and mobility - 5
up to 12 months
- +9 more secondary outcomes
Study Arms (2)
Pathfinder support
EXPERIMENTALPathfinder support with development of an individual care plan for the intervention patients and their informal caregivers, with the hospital physicians already inside the hospital setting. This will then be developed and improved further during up to twelve months after hospital release with the primary physician. The pathfinders will coordinate the ambulatory care team services and closely involve the primary physicians. The patients and their informal caregivers will be empowered and educated to achieve a stabilization or improvement in functionality, independence, quality of life, coping with disease, nutritional status and wound healing process. In the regular assessments they will be tested for functionality and nutritional parameters, quality of life and stress scores.
Control without pathfinder support
NO INTERVENTIONControl patients will not be supported by pathfinders. In regular assessments they will be tested for functionality and nutritional parameters, quality of life and stress scores.
Interventions
A pathfinder will support the patient with structured activities.
Eligibility Criteria
You may qualify if:
- will go back home after Hospital stay, AOK Patient, MiniMentalStateExamination MMSE score of at least 22, is living within 50 km range of the hospital
You may not qualify if:
- palliative status, planned readmission into hospital within next 4 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Erlangen-Nürnberg Medical Schoollead
- Hospital of the Order of St.John of God Regensburg, Barmherzige Brueder, Germanycollaborator
- Regensburg Physicians Network RAENcollaborator
- Friedrich-Alexander-Universität Erlangen-Nürnbergcollaborator
- AOK Bayerncollaborator
- Institute for Nursing Sciences, University of Bielefeld, Germanycollaborator
- Federal Association for Geriatrics, Germanycollaborator
- Federal Joint Committeecollaborator
- Institute for Community Medicine, University of Greifswald, Germanycollaborator
Study Sites (2)
Hospital of the Order of St.John of God Regensburg
Regensburg, Bavaria, 93049, Germany
Institute for Biomedicine of Aging, University of Erlangen-Nürnberg
Nuremberg, 90408, Germany
Related Publications (2)
Gehr TJ, Freiberger E, Sieber CC, Engel SA. A typology of caregiving spouses of geriatric patients without dementia: caring, worried, desperate. BMC Geriatr. 2021 Sep 6;21(1):483. doi: 10.1186/s12877-021-02425-1.
PMID: 34488636DERIVEDRimmele M, Wirth J, Britting S, Gehr T, Hermann M, van den Heuvel D, Kestler A, Koch T, Schoeffski O, Volkert D, Wingenfeld K, Wurm S, Freiberger E, Sieber C; TIGER consortium. Improvement of transitional care from hospital to home for older patients, the TIGER study: protocol of a randomised controlled trial. BMJ Open. 2021 Feb 8;11(2):e037999. doi: 10.1136/bmjopen-2020-037999.
PMID: 33558344DERIVED
Study Officials
- STUDY DIRECTOR
Cornel Sieber, Prof. Dr.
Institute for Biomedicine of Aging
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The patients data will be anonymized and entered into an electronic Case Report form. The Outcomes Assessor will only see the anonymized data.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 17, 2018
First Posted
May 1, 2018
Study Start
April 25, 2018
Primary Completion
June 30, 2020
Study Completion
February 28, 2021
Last Updated
March 3, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- The repository of the data set is under construction with the University.
- Access Criteria
- Anonymized data set will be available to interested Researchers upon reasonable request
The final anonymized trial data set will be available to the TIGER consortium. After completion of evaluation and dissemination by the TIGER-consortium, the goal is that an anonymized data set will be made available to interested Researchers upon reasonable request, being deposited in a repository of the University. During finalization of the study a detailed data sharing plan will be developed and introduced into this trial registry.